STOCK TITAN
  1. Home
  2. Sec-filings
  3. EYPT
  4. [Form 4] EyePoint, Inc. Insider Trading Activity

EyePoint (EYPT) CMO sells 4,875 shares after exercising stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

EyePoint, Inc. Chief Medical Officer Ramiro Ribeiro reported an option exercise-and-sale transaction in company stock. On June 30, 2026, he exercised options to acquire 4,875 shares of common stock at an exercise price of $8.26 per share, then sold 2,438 shares at a weighted average price of $15.0172 and 2,437 shares at $15.00 in open-market sales. Following these trades, his directly held common stock position was 0 shares, while his stock option holdings increased to 78,001 options with an exercise price of $8.26 expiring on January 3, 2035. A related footnote explains that 25% of this option grant vests on January 3, 2026, with the remainder vesting monthly over the following three years.

Positive

  • None.

Negative

  • None.

Insights

Routine option exercise paired with modest open-market sales; net position shifts from shares to options.

Chief Medical Officer Ramiro Ribeiro exercised stock options for 4,875 common shares at an exercise price of $8.26 per share and sold the same number of shares around $15.00. This is a classic exercise-and-sell pattern converting derivative awards into cash.

After the transactions, he held 0 common shares directly but maintained a sizeable option position of 78,001 options at $8.26 expiring on January 3, 2035. A footnote states 25% of this grant vests on January 3, 2026, with the remainder vesting monthly over three years, indicating ongoing equity-based incentives tied to service.

Because the filing does not quantify EyePoint’s total shares outstanding, the relative scale of 4,875 shares is unclear from this data alone. The pattern appears compensation-driven rather than a directional bet, as Ribeiro retains substantial unexercised options with long-dated expirations.

Insider Ribeiro Ramiro
Role Chief Medical Officer
Sold 4,875 shs ($73K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 2,437 $0.00 --
Exercise Stock Option (Right to Buy) 2,438 $0.00 --
Exercise Common Stock 2,437 $8.26 $20K
Exercise Common Stock 2,438 $8.26 $20K
Sale Common Stock 2,437 $15.00 $37K
Sale Common Stock 2,438 $15.0172 $37K
Holdings After Transaction: Stock Option (Right to Buy) — 78,001 shares (Direct, null); Common Stock — 2,437 shares (Direct, null)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.
Shares sold (trade 1) 2,438 shares at $15.0172 Open-market sale of common stock on June 30, 2026
Shares sold (trade 2) 2,437 shares at $15.00 Open-market sale of common stock on June 30, 2026
Total shares sold 4,875 shares Net-sell shares per transaction summary
Option exercise price $8.26 per share Exercise price for common stock acquired via options
Options exercised 4,875 underlying shares Exercise of stock options (2,438 + 2,437) on June 30, 2026
Options remaining 78,001 options Stock Option (Right to Buy) position after transactions
Common stock after 0 shares Directly held common stock following reported sales
Option expiration January 3, 2035 Expiration date of reported stock options
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
net-sell financial
"netBuySellDirection": "net-sell""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ribeiro Ramiro
(Last)(First)(Middle)
C/O EYEPOINT, INC
480 PLEASANT STREET, SUITE C400
(Street)
WATERTOWN MASSACHUSETTS 02472
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M2,437A$8.262,437D
Common Stock06/30/2026M2,438A$8.264,875D
Common Stock06/30/2026S2,437D$152,438D
Common Stock06/30/2026S2,438D$15.0172(1)0.00D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.2606/30/2026M2,437 (2)01/03/2035Common Stock2,437$0.0078,001D
Stock Option (Right to Buy)$8.2606/30/2026M2,438 (2)01/03/2035Common Stock2,438$0.0075,563D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.
Remarks:
/s/ Ron Honig, Attorney-in-Fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did EyePoint (EYPT) Chief Medical Officer Ramiro Ribeiro do in this Form 4 filing?

Ramiro Ribeiro exercised stock options for 4,875 EyePoint common shares at $8.26 and sold all 4,875 shares in open-market transactions around $15. This shifted his exposure from directly held shares to a larger remaining stock option position.

How many EyePoint (EYPT) shares did the CMO sell and at what prices?

He sold 2,438 shares at a weighted average price of $15.0172 and 2,437 shares at $15.00, totaling 4,875 shares. A footnote notes the $15.0172 price reflects multiple trades between $15.00 and $15.06 during the same day.

What options did the EyePoint (EYPT) CMO exercise in this Form 4?

Ribeiro exercised stock options labeled “Stock Option (Right to Buy)” to acquire 2,438 and 2,437 common shares, 4,875 in total, at an exercise price of $8.26 per share. These exercises converted part of his derivative awards into common stock before the same-day sales.

What are Ramiro Ribeiro’s EyePoint (EYPT) holdings after the reported transactions?

After the June 30, 2026 trades, Ribeiro directly held 0 shares of EyePoint common stock. However, transaction data shows he held 78,001 stock options with an $8.26 exercise price, providing continued potential equity exposure through long-dated options expiring in 2035.

How do the EyePoint (EYPT) CMO’s options vest according to the Form 4 footnote?

A footnote explains the option grant vests 25% on January 3, 2026, with the remaining 75% vesting ratably on a monthly basis over the next three years. This structure ties Ribeiro’s equity compensation to ongoing service and a multi-year time horizon.

Is this EyePoint (EYPT) insider transaction a net buy or net sell event?

The transaction summary shows a net-sell of 4,875 shares, as all shares acquired from option exercises were sold the same day. However, Ribeiro still holds 78,001 stock options, so his overall equity exposure is now concentrated in unexercised options rather than common shares.